Olanzapine or prochlorperazine added to antiemetic therapy for persistent chemotherapy-induced nausea: an NCORP phase 3 RCT
Year: 2026
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
DOI: 10.1093/jnci/djag404
Language: English
Subfield: Surgery
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W7225987774
